Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Pei-hui Xia"'
Autor:
Zi‐jun Xu, Ye Jin, Xin‐long Zhang, Pei‐hui Xia, Xiang‐mei Wen, Ji‐chun Ma, Jiang Lin, Jun Qian
Publikováno v:
Cancer Medicine, Vol 12, Iss 1, Pp 789-807 (2023)
Abstract Background CD300s are a group of proteins playing vital roles in immune responses. However, much is yet to be elucidated regarding the expression patterns and clinical significances of CD300s in cancers. Methods In this study, we comprehensi
Externí odkaz:
https://doaj.org/article/996674e00b094bc586be12ef3a6c79aa
Autor:
Ling‐yi Zhang, Ye Jin, Pei‐hui Xia, Jiang Lin, Ji‐chun Ma, Ting Li, Zi‐qi Liu, He‐lin Xiang, Chen Cheng, Zi‐jun Xu, Hong Zhou, Jun Qian
Publikováno v:
Cancer Medicine, Vol 10, Iss 21, Pp 7831-7846 (2021)
Abstract The role of B7‐H3 in acute myeloid leukemia (AML) is not fully understood. Two previous studies investigating its expression and significances in AML are partially different. In this study, we aimed to systematically characterize the genom
Externí odkaz:
https://doaj.org/article/9ad32924895f4fb18b848e1ee95e93d6
Autor:
Zi-Jun Xu, Xiang-Mei Wen, Yuan-Cui Zhang, Ye Jin, Ji-Chun Ma, Yu Gu, Xin-Yi Chen, Pei-Hui Xia, Wei Qian, Jiang Lin, Jun Qian
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
RNA N6-methyladenosine (m6A) is the most common and intensively studied RNA modification that critically regulates RNA metabolism, cell signaling, cell survival, and differentiation. However, the overall role of multiple m6A regulators in the tumor m
Externí odkaz:
https://doaj.org/article/1aba518a7f2041a793accea473e1b81f
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Acute myeloid leukemia (AML) is a heterogeneous disease related to a broad spectrum of molecular alterations. The successes of immunotherapies treating solid tumors and a deeper understanding of the immune systems of patients with hematologic maligna
Externí odkaz:
https://doaj.org/article/caf5bba21e1f42a6a9de3346a71e626e
Autor:
Shi-sen Wang, Zi-jun Xu, Ye Jin, Ji-chun Ma, Pei-hui Xia, Xiangmei Wen, Zhen-wei Mao, Jiang Lin, Jun Qian
Publikováno v:
PeerJ, Vol 9, p e11820 (2021)
Background Accumulating studies have been made to understand the association between CXC chemokine ligand-12 (CXCL12)/CXC chemokine receptor 4 (CXCR4) and acute myeloid leukemia (AML). However, large-scale data analysis of potential relationship betw
Externí odkaz:
https://doaj.org/article/e9522012a0c042718f8012062bb28d8c
Autor:
Ye Jin, Zi-jun Xu, Di Yu, Pei-hui Xia, Dong-ming Yao, Qian Yuan, Ting Li, He-lin Xiang, Ji-chun Ma, Xiang-mei Wen, Jiang Lin, Jun Qian
Publikováno v:
Clinical Laboratory; 2023, Vol. 69 Issue 11, p2333-2340, 8p
Autor:
Zi‐jun Xu, Ye Jin, Xin‐long Zhang, Pei‐hui Xia, Xiang‐mei Wen, Ji‐chun Ma, Jiang Lin, Jun Qian
Publikováno v:
Cancer Medicine. 12:789-807
CD300s are a group of proteins playing vital roles in immune responses. However, much is yet to be elucidated regarding the expression patterns and clinical significances of CD300s in cancers.In this study, we comprehensively investigated CD300s in a
Autor:
Xiang-mei Wen, Zi-jun Xu, Ji-chun Ma, Pei-hui Xia, Ye Jin, Xin-yi Chen, Wei Qian, Jiang Lin, Jun Qian
Necroptosis is a tightly regulated form of necrotic cell death that promotes inflammation and contributes to disease development. However, the potential roles of necroptosis-related genes (NRGs) in acute myeloid leukemia (AML) have not been elucidate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b367f96d1912d5a6ddc2e1ed3efd8b8
https://doi.org/10.21203/rs.3.rs-2408867/v1
https://doi.org/10.21203/rs.3.rs-2408867/v1
Autor:
Ye Jin, Ji-chun Ma, Chen Cheng, Zi-Jun Xu, Ting Li, He-Lin Xiang, Jun Qian, Zi-Qi Liu, Jiang Lin, Ling-Yi Zhang, Pei-hui Xia, Hong Zhou
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 21, Pp 7831-7846 (2021)
Cancer Medicine, Vol 10, Iss 21, Pp 7831-7846 (2021)
The role of B7‐H3 in acute myeloid leukemia (AML) is not fully understood. Two previous studies investigating its expression and significances in AML are partially different. In this study, we aimed to systematically characterize the genomic and im
Autor:
Ye, Jin, Shi Sen, Wang, Pei Hui, Xia, Qian, Yuan, Gao Fei, Xiao, Jiang, Lin, Jia Yan, Leng, Yu Juan, Ma, Jun, Qian
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 30(3)
To establish the droplet digital PCR (ddPCR) assay for the detection of NPM1 type A mutation in patients with acute myeloid leukemia (AML), and to evaluate its specificity, sensitivity and its value in clinical application.NPM1 mutant and wildtype